Skip to content
McGuireWoods
  • Who We Are
  • What We Do
  • Insights
    • Legal Alerts
    • News
    • Events
    • Podcasts
    • Blogs
  • Careers
  • Who We Are
  • What We Do
  • Insights
    • Legal Alerts
    • News
    • Events
    • Podcasts
    • Blogs
  • Careers
Back to Events
Events Banner 2600x660 1

12th International Pharmaceutical and Medical Device Compliance Congress

May 14-16, 2018 | 1-minute read
Save current page as PDF

Vienna
Austria

Partner Vivian Robinson participated in this event hosted by the International Society of Healthcare Compliance Professionals (ETHICS) and cosponsored by the Pharmaceutical Compliance Forum (PCF).

For more information please visit the event’s website.

  • Government Investigations & White Collar Litigation
  • London

Related Insights

Press Release

Former McGuireWoods Deputy Managing Partner Todd Steggerda Sworn In as U.S. Ambassador to the United Nations in Geneva

August 25, 2026
2-minute read
McGuireWoods congratulates former Deputy Managing Partner Todd Steggerda, who was sworn in Aug. 24, 2026, as the new U.S. Ambassador...
Press Release

McGuireWoods Lawyers Honored in 2027 Edition of The Best Lawyers in America

August 20, 2026
16-minute read
More than 230 McGuireWoods lawyers from the firm’s U.S. offices were selected for inclusion in the 2027 edition of The...
Press Release

McGuireWoods Attorneys Recognized as “Ones to Watch” By Best Lawyers

August 20, 2026
7-minute read
More than 100 attorneys in McGuireWoods’ U.S. offices were selected for inclusion on Best Lawyers’ 2027 “Ones to Watch” list, which...
Legal Alert

Department of War Launches Research Security Audits: Key Compliance Steps for Higher Education Institutions

August 18, 2026
On Aug. 17, 2026, the Department of War issued formal notifications to 30 domestic academic institutions directing them to initiate...
Legal Alert

FinCEN Kills Beneficial Ownership Reporting for U.S. Companies, but Foreign Filers Should Beware

August 13, 2026
The long saga of the Corporate Transparency Act’s (CTA) beneficial ownership reporting requirements has reached its final chapter — at...
McGuireWoods logo
  • About Us
  • Locations
  • Alumni
  • Subscribe to Alerts
  • Contact Us
  • Legal Notices
  • Fraud Alert
  • Logo Usage
  • McGuireWoods Consulting

© 2026 McGuireWoods. All rights reserved.

  • Privacy Statement
  • |
  • Cookies Policy
Email Disclaimer

Please note that unsolicited emails and attached information sent to McGuireWoods or a firm attorney via this website do not create an attorney-client relationship. If you are not a McGuireWoods client, do not send us any confidential information. We may not respond to unsolicited emails and do not consider them or attached information confidential. That means we may disclose unsolicited emails and attachments to third parties, and your unsolicited communications will not prevent any lawyer in our firm from representing a party and using the unsolicited communications against you. By clicking “accept” you confirm that you have read and understand this notice.

Accept